DRG Instruments GmbH

The DRG company, founded in 1970, is a family-owned, multi-national, medical equipment and diagnostics company. The DRG headquarter, DRG International, is located in the USA in Springfield, NJ.
The German division, DRG Instruments GmbH, was founded in 1973 and is located in Marburg. Since 1990, DRG Instruments develops and manufactures innovative immunoassays, both for routine and research applications. With the expansion of DRG in the early nineties, further Subsidiaries were founded in Poland, Russia, Czech Republic and Croatia.
DRG imunoassays are applied in the fields of endocrinology and gynecology, diabetes, prenatal/neonatal supervision, thyroid, cardiovascular and renal function, cancer diagnostics, iron metabolism, and infectious and autoimmune diseases. A wide range of new, occasionally unique, ELISA kits have been developed since the early nineties. The DRG assays compete effectively in both price and performance in all major world diagnostics markets.
To complete the diagnostic reagent line, DRG supplies the clinical laboratory with all necessary equipment, including a microtiter plate reader, and a fully automated Open Systems for microtiter plates. In addition, in 2013 DRG finished the development of a closed system, the DRG:HYBRiD-XL®, a fully automated analyzer for the simultaneous determination of immunoassays, immunoturbidimetry, as well as clinical chemistry.


CLIA, ELISA, Point-of-care diagnostics (POC), test development


Frauenbergstrasse 18
DE-35039 Marburg

Web: www.drg-diagnostics.de


Dr. Matthias Herkert
Direktor F&E
Tel.: +49 (0) 6421 – 170 031
E-Mail: herkert@drg-diagnostics.de